INS and Hyperinsulinemia: Notably, “insulin receptor binding” (GO: 0005158) provides a direct mechanistic bridge, supporting the hypothesis that hyperinsulinemia and insulin resistance may contribute to tumorigenesis via PI3K/AKT or MAPK pathways (Caruso, et al., 2025).